Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript

GILD earnings call for the period ending December 31, 2022.

Related Keywords

San Francisco ,California ,United States ,Japan ,China ,Maryland ,San Antonio ,Texas ,Amsterdam ,Noord Holland ,Netherlands ,Japanese ,Guyn Kim ,Guyn Kim Piper Sandler ,Olivia Brayer Cantor Fitzgerald ,Truvada Loes ,Johanna Mercier ,Geoff Meacham ,Simon Baker Redburn ,Jacquie Ross ,Tyler Van Buren Cowen ,Daiichi Sankyo ,Piper Sandler ,Randy Dickinson ,Christi Shaw ,Tyler Van Buren ,Mohit Bansal ,Robyn Karnauskas ,El Secunda ,Truvada Tripla ,Evan Seigerman ,Merdad Parsey ,Andrew Dickinson ,Atripla Loes ,Brian Abrahams ,Simon Baker ,Olivia Brayer ,America Merrill Lynch ,Chris Schott Jpmorgan ,Astrazeneca Daiichi ,Chris Schott ,Michael Yee Jefferies ,Colin Bristow ,Nicole Germino Truist ,Gilead Sciences ,European Commission ,Data Monitoring Committee ,Geoff Meacham Bank ,Community Therapeutics ,United Nations ,Pfizer ,Uk National Institute For Health ,Cantor Fitzgerald ,European Medicines Agency ,Department Of Corrections ,European Medicine Agency ,Company Analyst ,Wells Fargo ,Danielo Day ,Chief Executive Officer ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Trodelvy Slide ,Cell Therapy ,Care Excellence ,Gilead Biktarvy ,San Antonio Breast Cancer Symposium ,Independent Data Monitoring Committee ,Michael Yee ,Fargo Securities ,Umer Raffat ,Executive Officer ,Wells Fargo Securities ,